Related Experiment Video

Updated: May 28, 2026

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

Local drug delivery - the early Berlin experience: single drug administration versus sustained release

Ulrich Speck1, Bruno Scheller, Wolfgang Rutsch

  • 1Department of Radiology, Experimental Radiology, Charité, University Hospital, Berlin, Germany. ulrich/speck@charite.de

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
|October 27, 2011
PubMed

Insights

Local drug delivery effectively inhibits restenosis after coronary interventions. Paclitaxel-coated balloons demonstrated superior efficacy compared to drug-eluting stents and paclitaxel in contrast media.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Biomedical Engineering

Background:

  • Coronary interventions aim to improve outcomes by reducing target lesion revascularization.
  • Local drug delivery strategies are being explored to inhibit neointimal proliferation and restenosis.
  • Initial observations suggested potential benefits of ionic contrast media in coronary interventions.

Purpose of the Study:

  • To evaluate the efficacy of different local drug delivery methods for inhibiting neointimal proliferation.
  • To compare paclitaxel-coated balloons, sirolimus-eluting stents, and paclitaxel in contrast medium.
  • To investigate the effect of short drug exposure times on cell proliferation.

Main Methods:

  • A study in pigs compared three local drug delivery methods to the coronary artery.
  • Cell culture experiments were conducted to assess drug effects on cell proliferation.
  • Drug concentrations and tissue retention were analyzed.

Main Results:

  • Paclitaxel-coated balloons were the most effective in inhibiting neointimal proliferation.
  • Sirolimus-eluting stents with sustained drug release were less effective than coated balloons.
  • Paclitaxel in contrast medium showed the least efficacy among the tested methods.
  • Short drug exposure times were sufficient to inhibit cell proliferation, requiring higher concentrations.

Conclusions:

  • Paclitaxel-coated balloons represent a highly effective strategy for inhibiting neointimal proliferation.
  • Local drug delivery, particularly with paclitaxel-coated balloons, shows promise in preventing restenosis.
  • The long retention of paclitaxel in tissues may contribute to sustained efficacy.

More Related Videos

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Related Concept Videos

Modified-Release Drug Delivery Systems: Drug Release Characteristics01:22

Modified-Release Drug Delivery Systems: Drug Release Characteristics

Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.